Select Page

Patient-Centric Trial Design (PaCTD) Rating System

This resource from I AM ALS aims to inform the ALS community about each ALS clinical trial’s humaneness, accessibility and design efficiency, and highlight for drug developers the expectations of the community.

Expanded Access (Webinar)

This webinar from Northeast ALS Consortium (NEALS) explains what expanded access is and how it connects patients with life-threatening illnesses to experimental drugs.

Right to Try (Webinar)

This webinar from Northeast ALS Consortium (NEALS) details the history and legal and ethical considerations of Right to Try legislation, which gives terminally ill patients the right to ask companies for access to their investigational drug.